go to main content
10 August 2017

Sita Vermeulen (Health Evidence) has been awarded an NWO Vidi grant of 800 K€ for the project “Personalizing BCG immunotherapy in bladder cancer: a novel approach using germline and acquired DNA variants”.

A good therapy choice in non-muscle invasive bladder cancer requires a test that can predict who will and who will not respond to BCG immunotherapy. Vermeulen’s research measures DNA variants in the genes of the patient and the bladder tumor and selected immune parameters to facilitate the development of such a test.

  • Want to know more about these subjects? Click on the buttons below for more news.

    Health Evidence

Related news items

Body composition is more important than BMI for renal cancer survival rates

11 January 2022 Body composition is important for survival rates in renal cell cancer. Research from the Radboudumc shows that low muscle quality and low organ fat are associated with poor survival. This involves different stages of renal cancer, ranging from stage I-III to stage IV. read more

Millions of euros for study of laser treatment for glioblastoma

2 April 2021 A research group from Radboudumc and UMC Utrecht is to investigate laser treatment of a rare brain tumor, glioblastoma. 3.9 million euros has been made available for the research by Zorginstituut Nederland and ZonMw, under the auspices of the Subsidy Scheme for Promising Care. read more

Plugging the gap ZonMw/Health Holland grant

3 March 2020 RIMLS en RIHS researchers Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt and Janneke Grutters have been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM). read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019 With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success. read more

How do we keep new technology affordable to improve the lives of people?

16 May 2019 Improving healthcare by means of new technological developments? We need to change the entire approach for evaluating the true impact , says Maroeska Rovers. By bringing together all stakeholders from the beginning, millions of euros can be saved. read more

Bart Kiemeney among most cited researchers

13 December 2018 Bart Kiemeney made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists. read more